AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $281,000 | -12.5% | 18,573 | -14.6% | 0.14% | -42.3% |
| Q2 2020 | $321,000 | +34.9% | 21,759 | +23.3% | 0.25% | -14.9% |
| Q1 2020 | $238,000 | -69.6% | 17,642 | -45.5% | 0.29% | -49.4% |
| Q4 2019 | $782,000 | +180.3% | 32,357 | +450.9% | 0.57% | +160.7% |
| Q1 2019 | $279,000 | -86.1% | 5,873 | -80.2% | 0.22% | -88.4% |
| Q2 2018 | $2,001,000 | +44.8% | 29,629 | +16.3% | 1.88% | +80.1% |
| Q1 2018 | $1,382,000 | +228.3% | 25,472 | +261.2% | 1.04% | +309.8% |
| Q4 2017 | $421,000 | – | 7,053 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |